[1]郭 明,郑继伟,马丽平.25(OH)D3与糖尿病视网膜病变的关系研究[J].医学信息,2018,31(08):99-100.[doi:10.3969/j.issn.1006-1959.2018.08.031]
　GUO Ming,ZHENG Ji-wei,MA Li-ping.Study on the Relationship between 25(OH)D3 and Diabetic Retinopathy[J].Journal of Medical Information,2018,31(08):99-100.[doi:10.3969/j.issn.1006-1959.2018.08.031]
点击复制

25(OH)D3与糖尿病视网膜病变的关系研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年08期
页码:
99-100
栏目:
临床研究
出版日期:
2018-04-15

文章信息/Info

Title:
Study on the Relationship between 25(OH)D3 and Diabetic Retinopathy
文章编号:
1006-1959（2018）08-0099-02
作者:
郭 明; 郑继伟; 马丽平
佳木斯市中心医院眼科，黑龙江 佳木斯 154002
Author(s):
GUO Ming; ZHENG Ji-wei; MA Li-ping
Department of Ophthalmology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China
关键词:
25(OH)D3; 糖尿病视网膜病变; 总胆固醇
Keywords:
Key words：25(OH)D3; Diabetic etinopatrhy; Total cholesterol
分类号:
R587.2；R774.1
DOI:
10.3969/j.issn.1006-1959.2018.08.031
文献标志码:
A
摘要:
目的 探讨25(OH)D3与糖尿病视网膜病变之间的关系。方法 回顾性分析2016年1月~2017年3月我科收治的2型糖尿病患者83例，根据患者是否合并视网膜病变，分为观察组43例和对照组40例。所有患者检测并比较血糖（FBG）水平、总胆固醇（TC）、甘油三酯（TG）、高密度脂蛋白（HDLC）、低密度脂蛋白（LDL-C）、糖化血红蛋白（HbA1c）以及25(OH)D3的水平。结果 两组患者在TG（t=5.572，P=0.037）、HDLC（t=5.548，P=0.037）、HbA1c（t=6.627，P=0.012）、25（OH）D3（t=9.738，P=0.000）等临床生化资料比较中差异均具有统计学意义（P＜0.05）。对25(OH)D3的Pearson进行相关性分析后发现，25(OH)D3与T2DM病程（r=0.163，P=0.027）、TC（r=0.170，P=0.025）、HDLC（r=0.177，P=0.023）、LDLC（r=0.185，P=0.015）具有高度相关性；偏相关显示，25(OH)D3与TC、HDLC、LDLC具有相关性。结论 25(OH)D3水平能够反映糖尿病视网膜病变患者的疾病发展状态，在诊断及评估中具有一定的参考价值。
Abstract:
Abstract：Objective To investigate the relationship between 25(OH)D3 and diabetic retinopathy.Methods Retrospective analysis of 83 patients with type 2 diabetes treated in our department from January 2016 to March 2017 was divided into observation group(43 cases)and control group(40 cases)according to whether patients had retinopathy.All patients tested and compared blood glucose(FBG) levels,total cholesterol(TC),triglyceride(TG),high-density lipoprotein(HDLC),low-density lipoprotein(LDL-C),glycated hemoglobin (HbA1c),and 25(OH)D3 level.Results The two groups were in TG(t=5.572,P=0.037),HDLC(t=5.548,P=0.037),HbA1c(t=6.627,P=0.012),25(OH)D3(t=9.738,P=0.000),the differences in clinical and biochemical data were statistically significant(P<0.05).Pearson correlation analysis of 25(OH)D3 revealed 25(OH)D3 and T2DM disease course(r=0.163,P=0.027),TC(r=0.170,P=0.025),HDLC(r=0.177,P=0.023)and LDLC(r=0.185,P=0.015)were highly correlated;partial correlation showed that 25(OH)D3 correlated with TC,HDLC,and LDLC.Conclusion The level of 25(OH)D3 can reflect the disease state of patients with diabetic retinopathy.It has certain reference value in diagnosis and evaluation.

参考文献/References:

[1]韩睿,朱钊,刘华,等.昆明地区家族性2型糖尿病伴糖尿病视网膜病变患者中血清25羟维生素D3的检测意义[J].重庆医科大学学报,2015,40(7):1006-1011.
[2]李锦,李晓华,王勤.25-羟基维生素D3水平与2型糖尿病视网膜病变的关系研究[J].河北医药,2014,36(8):1206-1207.
[3]杨萍,孙书明.血清25羟维生素D3水平与2型糖尿病视网膜病变的关系研究[J].眼科新进展,2014,34(6):583-585.
[4]陈雄,龚小花,陈恩德,等.血清25羟维生素D3水平与2型糖尿病视网膜病变的关系[J].浙江医学,2011,33(10):1459-1462.
[5]王晓丽,胡士涛,付荣,等.25-羟维生素D水平与糖尿病视网膜病变的关系[J].医学研究杂志,2014,43(2):108-111.

相似文献/References:

[1]闫宇梅.血清胱抑素C及同型半胱氨酸与2型糖尿病 视网膜病变的相关性分析[J].医学信息,2018,31(17):89.[doi:10.3969/j.issn.1006-1959.2018.17.027]
　YAN Yu-mei.Correlation between Serum Cystatin C and Homocysteine and Type 2 Diabetic Retinopathy[J].Journal of Medical Information,2018,31(08):89.[doi:10.3969/j.issn.1006-1959.2018.17.027]
[2]罗妮娜,金昌德,陈文莉.中西医结合护理在老年糖尿病视网膜病变低视力患者中应用及效果观察[J].医学信息,2018,31(19):165.[doi:10.3969/j.issn.1006-1959.2018.19.052]
　LUO Ni-na,JIN Chang-de,CHEN Wen-li.Application and Effect of Integrated Traditional Chinese and Western Medicine Nursing in Elderly Patients with Diabetic Retinopathy with Low Visual[J].Journal of Medical Information,2018,31(08):165.[doi:10.3969/j.issn.1006-1959.2018.19.052]
[3]宋晨音.他汀类药物在糖尿病治疗中的研究[J].医学信息,2022,35(17):166.[doi:10.3969/j.issn.1006-1959.2022.17.045]
　SONG Chen-yin.Study of Statins in the Treatment of Diabetes Mellitus[J].Journal of Medical Information,2022,35(08):166.[doi:10.3969/j.issn.1006-1959.2022.17.045]
[4]苟青青,李 鸿.糖尿病相关眼部改变及并发症的研究[J].医学信息,2022,35(18):153.[doi:10.3969/j.issn.1006-1959.2022.18.043]
　GOU Qing-qing,LI Hong.Study on Diabetes-related Ocular Changes and Complications[J].Journal of Medical Information,2022,35(08):153.[doi:10.3969/j.issn.1006-1959.2022.18.043]
[5]马 斌,王彩星,王金虹.基于文献计量学的我国2型糖尿病护理研究现状及热点分析[J].医学信息,2021,34(22):12.[doi:10.3969/j.issn.1006-1959.2021.22.004]
　MA Bin,WANG Cai-xing,WANG Jin-hong.Analysis of Current Status and Hot Spots in Nursing Research of Type 2 Diabetes Mellitus in China Based on Bibliometrics[J].Journal of Medical Information,2021,34(08):12.[doi:10.3969/j.issn.1006-1959.2021.22.004]
[6]潘 浩.依帕司他片辅助治疗对糖尿病视网膜病变患者SOD、TAOC及TNF-α水平的影响[J].医学信息,2020,33(05):100.[doi:10.3969/j.issn.1006-1959.2020.05.030]
　PAN Hao.Effects of Adjuvant Epalrestat on SOD,TAOC and TNF-α Levels in Patients with Diabetic Retinopathy[J].Journal of Medical Information,2020,33(08):100.[doi:10.3969/j.issn.1006-1959.2020.05.030]
[7]孙天慧,谭晓霞,连晓芬,等.2型糖尿病合并视网膜病变的影响因素分析[J].医学信息,2020,33(21):94.[doi:10.3969/j.issn.1006-1959.2020.21.027]
　SUN Tian-hui,TAN Xiao-xia,LIAN Xiao-fen,et al.Analysis of Influencing Factors of Type 2 Diabetes with Retinopathy[J].Journal of Medical Information,2020,33(08):94.[doi:10.3969/j.issn.1006-1959.2020.21.027]
[8]李 娟,冯双双,康京京,等.尿β2微球蛋白水平与2型糖尿病患者视网膜病变和肾脏病变的相关性[J].医学信息,2020,33(19):99.[doi:10.3969/j.issn.1006-1959.2020.19.029]
　LI Juan,FENG Shuang-shuang,KANG Jing-jing,et al.Correlation Between Urine β2 Microglobulin Level and Retinopathy and Nephropathy in Type 2 Diabetic Patients[J].Journal of Medical Information,2020,33(08):99.[doi:10.3969/j.issn.1006-1959.2020.19.029]
[9]彭 越,高 宇,王云飞,等.VEGF在糖尿病视网膜病变发病机制中的作用[J].医学信息,2021,34(05):36.[doi:10.3969/j.issn.1006-1959.2021.05.011]
　PENG Yue,GAO Yu,WANG Yun-fei,et al.The Role of VEGF in the Pathogenesis of Diabetic Retinopathy[J].Journal of Medical Information,2021,34(08):36.[doi:10.3969/j.issn.1006-1959.2021.05.011]
[10]杨文彦.雷珠单抗玻璃体腔注射联合激光治疗对糖尿病视网膜病变患者视力水平的影响[J].医学信息,2023,36(11):110.[doi:10.3969/j.issn.1006-1959.2023.11.021]
　YANG Wen-yan.Effect of Intravitreal Injection of Ranibizumab Combined with Laser Therapy on Visual Acuity in Patients with Diabetic Retinopathy[J].Journal of Medical Information,2023,36(08):110.[doi:10.3969/j.issn.1006-1959.2023.11.021]

更新日期/Last Update: 2018-04-15